1. Tauroursodeoxycholic Acid Inhibited Apoptosis and Oxidative Stress in H 2 O 2 -Induced BMSC Death via Modulating the Nrf-2 Signaling Pathway: the Therapeutic Implications in a Rat Model of Spinal Cord Injury.
- Author
-
Weng J, Wang L, Wang K, Su H, Luo D, Yang H, Wen Y, Wu Q, and Li X
- Subjects
- Animals, Mesenchymal Stem Cell Transplantation methods, Rats, Male, Cell Survival drug effects, Taurochenodeoxycholic Acid pharmacology, Taurochenodeoxycholic Acid therapeutic use, Spinal Cord Injuries pathology, Spinal Cord Injuries metabolism, Spinal Cord Injuries drug therapy, Apoptosis drug effects, NF-E2-Related Factor 2 metabolism, Signal Transduction drug effects, Oxidative Stress drug effects, Mesenchymal Stem Cells metabolism, Mesenchymal Stem Cells drug effects, Disease Models, Animal, Hydrogen Peroxide pharmacology, Rats, Sprague-Dawley
- Abstract
Spinal cord injury (SCI) is a prevalent and significant injury to the central nervous system, resulting in severe consequences. This injury is characterized by motor, sensory, and excretory dysfunctions below the affected spinal segment. Transplantation of bone marrow mesenchymal stem cells (BMSCs) has emerged as a potential treatment for SCI. However, the low survival as well as the differentiation rates of BMSCs within the spinal cord microenvironment significantly limit their therapeutic efficiency. Tauroursodeoxycholic acid (TUDCA), an active ingredient found in bear bile, has demonstrated its neuroprotective, antioxidant, and antiapoptotic effects on SCI. Thus, the present study was aimed to study the possible benefits of combining TUDCA with BMSC transplantation using an animal model of SCI. The results showed that TUDCA significantly enhanced BMSC viability and reduced apoptosis (assessed by Annexin V-FITC, TUNEL, Bax, Bcl-2, and Caspase-3) as well as oxidative stress (assessed by ROS, GSH, SOD, and MDA) both in vitro and in vivo. Additionally, TUDCA accelerated tissue regeneration (assessed by HE, Nissl, MAP2, MBP, TUJ1, and GFAP) and improved functional recovery (assessed by BBB score) following BMSC transplantation in SCI. These effects were mediated via the Nrf-2 signaling pathway, as evidenced by the upregulation of Nrf-2, NQO-1, and HO-1 expression levels. Overall, these results indicate that TUDCA could serve as a valuable adjunct to BMSC transplantation therapy for SCI, potentially enhancing its therapeutic efficacy., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF